Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROPHYLOXITIN – Intermittent vs continuous cefoxitin infusion for prevention of surgical site infection in colorectal surgery
2024-515146-16-00Phase 3Completed
- Sponsor
- CHU de Poitiers
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of cefoxitin in surgical site infection (SSI) (2 arms), sponsored by CHU de Poitiers. Primary endpoint: Proportion of patients with any surgical site infection within 30 days after surgery. Started Aug 2024; status: completed.
02
Drugs
cefoxitin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on 2024-515146-16-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515146-16-00.